查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595231

患者血液管理市場：按產品、組件和最終用戶分類 - 全球預測 2025-2030 年

Patient Blood Management Market by Product (Accessories, Instrument, Reagent & Kit), Component (Plasma, Whole Blood & Red Blood Cell), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年患者血液管理市場價值為 158.5 億美元，預計到 2024 年將達到 171.7 億美元，複合年成長率為 8.00%，到 2030 年將達到 271.7 億美元。

患者血液管理 (PBM) 是一種多學科、基於證據的方法，用於最佳化可能需要輸血的患者的護理。 PBM 的範圍包括減少不必要的輸血、最大限度地減少出血以及根據患者個體需求量身定做的特定策略來改善患者的治療結果。這種方法對於解決醫療機構中血液供不應求、輸血相關併發症和成本控制的挑戰至關重要。 PBM 在外科、腫瘤學、創傷護理和慢性病管理等各個醫療領域都有應用，醫院、診所和血庫是主要的最終使用者。市場成長受到慢性病和外科疾病盛行率上升、輸血風險意識不斷增強以及細胞拯救和血液替代等技術進步的影響。鼓勵實施 PBM 的法律規範將進一步刺激市場擴張。透過投資增強血液儲存、自動化資料收集和實現個人化醫療的技術來抓住市場機會。非侵入性血紅素監測和新型紅血球生成刺激因子製劑的開發也帶來了機會。然而，實施成本高、缺乏意識以及不願偏離傳統輸血做法等挑戰正在阻礙市場成長。研究、開發和創新可以集中於開發具有成本效益的 PBM 解決方案和教育計劃，以提高認知度和採用率。分析 PBM 實施後的患者結果可以提供有關療效和安全性的寶貴資料，並吸引更多的醫療保健提供者。 PBM 市場的本質是動態的，受到技術進步和監管變化的驅動。成功應對這一情況需要相關人員掌握新興趨勢，促進合作，並積極應對血液濫用和稀缺挑戰，以改善業務成果，同時改善患者護理和安全。

主要市場統計
基準年[2023] 158.5億美元
預測年份 [2024] 171億美元
預測年份 [2030] 271.7億美元
複合年成長率（%） 8.00%

市場動態：快速發展的患者血液管理市場的關鍵市場洞察

供需的動態交互作用正在改變患者血液管理市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 血液疾病急劇增加導致交通事故增加，需要血液管理
    • 各種患者血液管理指南的可用性
    • 政府鼓勵捐血的舉措
  • 市場限制因素
    • 自動化系統高成本
  • 市場機會
    • 患者血液管理的技術進步
    • 先進血液儲存和輸血設備的開發
  • 市場挑戰
    • 醫護人員短缺

波特五力：駕馭病患血液管理市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解患者血液管理市場的外部影響

外部宏觀環境因素在塑造患者血液管理市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解病患血液管理市場的競爭狀況

患者血液管理市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣病患血液管理市場供應商的績效評估

FPNV 定位矩陣是評估病患血液管理市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃患者血液管理市場的成功之路

患者血液管理市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於血液疾病的蔓延導致交通事故增加，因此需要進行血液管理
      • 各種患者血液管理指南的可用性
      • 政府鼓勵捐血的舉措
    • 抑制因素
      • 自動化系統高成本
    • 機會
      • 患者血液管理的技術進步
      • 先進血液儲存及輸血設備的研發
    • 任務
      • 醫護人員短缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章病患血液管理市場：依產品

  • 配件
    • 血袋
    • 注射器和針頭
    • 管瓶和管
  • 裝置
    • 血液培養檢測裝置
      • 自動血液培養系統
      • 實驗室設備支援
    • 血液處理設備
      • 血球處理設備
      • 離心機
    • 血液儲存裝置
      • 醫用冷凍庫
      • 醫用冰箱
    • 輸血裝置
      • 血漿分離裝置
      • 細胞救援系統
      • 血漿及血漿成分分離設備
    • 診斷和測試設備
      • 血型分析儀
      • 血液分析儀
      • NGS平台
      • PCR裝置
  • 試劑和套件
    • 檢測試劑套件
    • 血培養基
    • 血型測定試劑
    • 玻片染色試劑
  • 軟體
    • 血庫管理軟體
    • 輸血管理軟體

第7章患者血液管理市場：依組成部分

  • 電漿
  • 全血和紅血球

第8章患者血液管理市場：依最終用戶分類

  • 血庫
  • 診斷診所和病理實驗室
  • 醫院

第9章美洲患者血液管理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太患者血液管理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的病患血液管理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • LivaNova, Inc.
  • Macopharma, Inc.
  • Merck & Co., Inc.
  • Terumo Corporation
Product Code: MRR-0372549B1FF1

The Patient Blood Management Market was valued at USD 15.85 billion in 2023, expected to reach USD 17.10 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 27.17 billion by 2030.

Patient Blood Management (PBM) is a multidisciplinary, evidence-based approach to optimizing the care of patients who might need transfusion. The scope of PBM involves reducing unnecessary transfusions, minimizing blood loss, and improving patient outcomes through specific strategies tailored to individual patient needs. This approach is essential as it addresses the challenges of blood supply shortages, transfusion-related complications, and cost containment in healthcare settings. PBM is applied in various medical fields, including surgery, oncology, trauma care, and chronic disease management, with hospitals, clinics, and blood banking institutions serving as primary end-users. Market growth is influenced by the rising prevalence of chronic and surgical conditions, increasing awareness about the risks of transfusion, and advances in technologies such as cell salvage and blood substitutes. Regulatory frameworks encouraging PBM practices further spur market expansion. Opportunities in the market can be seized by investing in technologies that enhance blood conservation, automate data collection, and enable personalized medicine. The development of non-invasive hemoglobin monitoring and new erythropoiesis-stimulating agents also presents opportunities. However, challenges such as high implementation costs, lack of awareness, and reluctance to deviate from traditional transfusion practices impede market growth. Research and innovation can focus on developing cost-effective PBM solutions and educational programs to increase awareness and adoption. Analyzing patient outcomes post-PBM implementation can provide valuable data on efficacy and safety, attracting more healthcare providers to the practice. The nature of the PBM market is dynamic, propelled by technological advancements and regulatory changes. Successfully navigating this landscape requires stakeholders to stay informed on emerging trends, foster collaborations, and proactively address the challenges of blood misuse and scarcity, ensuring business growth while enhancing patient care and safety.

KEY MARKET STATISTICS
Base Year [2023] USD 15.85 billion
Estimated Year [2024] USD 17.10 billion
Forecast Year [2030] USD 27.17 billion
CAGR (%) 8.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Patient Blood Management Market

The Patient Blood Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need of blood management due to rising incidences of road accidents with the surge in the prevalence of blood disorders
    • Availability of various patient blood management guidelines
    • Government initiatives encouraging blood donations
  • Market Restraints
    • High cost of the automated systems
  • Market Opportunities
    • Technology advancements in the patient blood management
    • Development of advanced blood storage and blood transfusion devices
  • Market Challenges
    • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Patient Blood Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Patient Blood Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Patient Blood Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Patient Blood Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Patient Blood Management Market

A detailed market share analysis in the Patient Blood Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Patient Blood Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Patient Blood Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Patient Blood Management Market

A strategic analysis of the Patient Blood Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Patient Blood Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Bio-Rad Laboratories, Inc., Biomerieux SA, Danaher Corporation, F. Hoffmann-La Roche LTD., Fresenius Se & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Immucor, Inc., LivaNova, Inc., Macopharma, Inc., Merck & Co., Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Patient Blood Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Instrument, Reagent & Kit, and Software. The Accessories is further studied across Blood Bag, Syringe & Needle, and Vial & Tube. The Instrument is further studied across Blood Culture Screening Device, Blood Processing Device, Blood Storage Device, Blood Transfusion Device, and Diagnostic & Testing Instrument. The Blood Culture Screening Device is further studied across Automated Blood Culture System and Supporting Laboratory Equipment. The Blood Processing Device is further studied across Blood Cell Processor and Centrifuges. The Blood Storage Device is further studied across Medical Freezer and Medical Refrigerator. The Blood Transfusion Device is further studied across Apheresis Machine, Cell Salvage System, and Plasma & Plasma Component Separator. The Diagnostic & Testing Instrument is further studied across Blood Grouping Analyzer, Hematology Analyzer, NGS Platform, and PCR Instrument. The Reagent & Kit is further studied across Assay Kit, Blood Culture Media, Blood Typing Reagent, and Slide Staining Reagent. The Software is further studied across Blood Bank Management Software and Transfusion Management Software.
  • Based on Component, market is studied across Plasma and Whole Blood & Red Blood Cell.
  • Based on End User, market is studied across Blood Bank, Diagnostic Clinic & Pathology Lab, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need of blood management due to rising incidences of road accidents with the surge in the prevalence of blood disorders
      • 5.1.1.2. Availability of various patient blood management guidelines
      • 5.1.1.3. Government initiatives encouraging blood donations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the automated systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technology advancements in the patient blood management
      • 5.1.3.2. Development of advanced blood storage and blood transfusion devices
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of medical professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Patient Blood Management Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Blood Bag
    • 6.2.2. Syringe & Needle
    • 6.2.3. Vial & Tube
  • 6.3. Instrument
    • 6.3.1. Blood Culture Screening Device
      • 6.3.1.1. Automated Blood Culture System
      • 6.3.1.2. Supporting Laboratory Equipment
    • 6.3.2. Blood Processing Device
      • 6.3.2.1. Blood Cell Processor
      • 6.3.2.2. Centrifuges
    • 6.3.3. Blood Storage Device
      • 6.3.3.1. Medical Freezer
      • 6.3.3.2. Medical Refrigerator
    • 6.3.4. Blood Transfusion Device
      • 6.3.4.1. Apheresis Machine
      • 6.3.4.2. Cell Salvage System
      • 6.3.4.3. Plasma & Plasma Component Separator
    • 6.3.5. Diagnostic & Testing Instrument
      • 6.3.5.1. Blood Grouping Analyzer
      • 6.3.5.2. Hematology Analyzer
      • 6.3.5.3. NGS Platform
      • 6.3.5.4. PCR Instrument
  • 6.4. Reagent & Kit
    • 6.4.1. Assay Kit
    • 6.4.2. Blood Culture Media
    • 6.4.3. Blood Typing Reagent
    • 6.4.4. Slide Staining Reagent
  • 6.5. Software
    • 6.5.1. Blood Bank Management Software
    • 6.5.2. Transfusion Management Software

7. Patient Blood Management Market, by Component

  • 7.1. Introduction
  • 7.2. Plasma
  • 7.3. Whole Blood & Red Blood Cell

8. Patient Blood Management Market, by End User

  • 8.1. Introduction
  • 8.2. Blood Bank
  • 8.3. Diagnostic Clinic & Pathology Lab
  • 8.4. Hospital

9. Americas Patient Blood Management Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Patient Blood Management Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Patient Blood Management Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Asahi Kasei Medical Co. Ltd.
  • 3. B. Braun Melsungen AG
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomerieux SA
  • 6. Danaher Corporation
  • 7. F. Hoffmann-La Roche LTD.
  • 8. Fresenius Se & Co. KGaA
  • 9. Grifols, S.A.
  • 10. Haemonetics Corporation
  • 11. Immucor, Inc.
  • 12. LivaNova, Inc.
  • 13. Macopharma, Inc.
  • 14. Merck & Co., Inc.
  • 15. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. PATIENT BLOOD MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PATIENT BLOOD MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PATIENT BLOOD MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PATIENT BLOOD MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PATIENT BLOOD MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PATIENT BLOOD MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SYRINGE & NEEDLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VIAL & TUBE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOMATED BLOOD CULTURE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CELL PROCESSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL FREEZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL REFRIGERATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APHERESIS MACHINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA & PLASMA COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD GROUPING ANALYZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY NGS PLATFORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PCR INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TYPING REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SLIDE STAINING REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRANSFUSION MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY WHOLE BLOOD & RED BLOOD CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CLINIC & PATHOLOGY LAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 307. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 308. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 309. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 310. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT PATIENT BLOOD MANAGEMENT